RSS   Newsletter   Contact   Advertise with us
Post Online Media

Aquinnah Pharmaceuticals appoints two executives

Aquinnah PharmaceuticalsAquinnah Pharmaceuticals, a pharmaceutical company, announced that Bob Carpenter will join the board and Duane Burnett will lead chemistry R&D as vice president of medicinal chemistry.
Mr. Carpenter founded a number of successful biotech companies that he took public, including Integrated Genetics and GelTex Pharmaceuticals, both of which were acquired by Genzyme (now Sanofi Genzyme).

Mr. Carpenter served on the Board of Genzyme from 1994 to 2011, most recently as Lead Director.

He also founded Boston Medical Investors in 1994 and currently serves as a Director of Good Start Genetics, Olaris Therapeutics, Immuneering, Hydra Biosciences, and Lysosomal Therapeutics.

Mr. Carpenter is a graduate of West Point, Stanford University and holds an MBA from Harvard Business School.

Dr. Burnett is a medicinal chemistry leader with nearly 30 years of experience at leading pharmaceutical companies including Schering Plough, Merck and Forum.

Dr. Burnett's impressive list of awards includes: National Inventor of the Year, American Chemical Society Hero of Chemistry Award, Thomas Alva Edison Patent Award, and Prix Galien USA – Best Medical Agent Finalist.

In addition, Dr. Burnett has 60 published papers and 108 granted or published patents and applications.


 LATEST MOVES FROM Massachusetts 


We use cookies to ensure that we give you the best experience on our website. Please allow cookies for fully-functioning website.

Allow Cookies Privacy Policy